Orthopedic Biomaterials Market Report 2026

Orthopedic Biomaterials Market Overview

• Orthopedic Biomaterials market size has reached to $22.6 billion in 2025 • Expected to grow to $36.67 billion in 2030 at a compound annual growth rate (CAGR) of 9.1% • Growth Driver: Rising Musculoskeletal Disorder Incidence Fuels Growth Of The Orthopedic Biomaterials Market • Market Trend: Increasing Focus On Product Innovations To Provide Reliable Services To Their Customers • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Orthopedic Biomaterials Market?

Orthopedic biomaterials are materials intended to be inserted into the human body as constituents of devices designed to perform certain biological functions by either substituting or repairing various tissues, such as bones, cartilage, ligaments, tendons, and others. The orthopedic biomaterials market covered in this report is segmented by material type into ceramics and bioactive glasses, calcium phosphate cement, polymers, metal, and composites. Polymers are used as orthopedic biomaterials intended to be inserted into the human body as constituents. The various applications are orthopedic implants, joint replacement/reconstruction, bio-resorbable tissue fixation, orthobiologics, and viscosupplementation. These are used by various end-users such as hospitals, clinics, and others.

What Is The Orthopedic Biomaterials Market Growth Forecast?

The orthopedic biomaterials market size is expected to see strong growth in the next few years. It will grow to $36.67 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to growth in sports injuries, demand for personalized implants, increasing osteoarthritis prevalence, advancements in composite biomaterials, rising healthcare expenditure. Major trends in the forecast period include rising use of bioactive materials, growing demand for joint replacement solutions, increased adoption of lightweight implants, expansion of minimally invasive orthopedic procedures, focus on long-term implant durability.

Global Orthopedic Biomaterials Market Segmentation

1) By Material Type: Ceramics And Bioactive Glasses, Calcium Phosphate Cements, Polymers, Metal, Composites 2) By Application: Orthopedic Implants, Joint Replacement/Reconstruction, Bio-Resorbable Tissue Fixation, Other Applications 3) By End-User: Hospitals, Clinics, Other End-Users Subsegments: 1) By Ceramics And Bioactive Glasses: Bioactive Glasses, Alumina Ceramics, Zirconia Ceramics 2) By Calcium Phosphate Cements: Hydroxyapatite (HA) Cements, Tricalcium Phosphate (TCP) Cements, Biphasic Calcium Phosphate Cements 3) By Polymers: Polyethylene (PE), Polymethyl Methacrylate (PMMA), Polyetheretherketone (PEEK) 4) By Metal: Titanium Alloys, Stainless Steel, Cobalt-Chromium Alloys 5) By Composites: Fiber-Reinforced Composites, Polymer-Ceramic Composites, Metal-Ceramic Composites

What Is The Driver Of The Orthopedic Biomaterials Market?

The rise in the incidence of musculoskeletal disorders is expected to drive the orthopedic biomaterials market. Musculoskeletal disorders induce fractures, swelling, and discomfort in the joints, ligaments, and tendons that cause movement disabilities. The burden of musculoskeletal conditions is known to increase with age. For instance, in January 2024, according to the GOV.UK, a UK-based government department, in 2023, 18.4% of individuals aged 16 and older reported having a long-term musculoskeletal (MSK) condition, marking an increase from the 17.6% prevalence recorded in 2022. Hence, the incidence of musculoskeletal disorders is projected to drive the orthopedic biomaterials industry.

Key Players In The Global Orthopedic Biomaterials Market

Major companies operating in the orthopedic biomaterials market are Medtronic PLC, Johnson & Johnson, Stryker Corporation, Zimmer Biomet, Smith & Nephew, NuVasive, Wright Medical Group N.V., Orthofix Medical Inc., Acelity, Conmed Corporation, Aesculap, Seaspine Holdings Corporation, Bone Support AB, Bioventus, K2M Group Holdings Inc., MTF Biologics, Amedica Corporation, TPL Biomed, Fidia Farmaceutici S.p.A., OsteoRemedies, Xtant Medical, RTI Surgical Holdings Inc., LifeNet Health, VIVEX Biologics, DJO Global, MedShape, Evonik Industries AG, Heraeus Medical, 3M Company, Collagen Solutions plc

Global Orthopedic Biomaterials Market Trends and Insights

Major companies operating in the orthopedic biomaterials market are focusing on innovative products, such as tendon fixation device, to drive revenues in their market. A tendon fixation device is a medical instrument or implant used in orthopedic surgery to secure tendons, ligaments, or soft tissues to bone. For instance, in June 2023, Acuitive Technologies Inc., a US-based company that develops innovative orthopedic biomaterial technologies, launched a new tendon fixation device. This novel ACL device offers orthopedic surgeons a unique design thanks to a tendon-friendly spiral thread made of citregen, a next-generation resorbable material with special molecular and mechanical characteristics. This special material technology would enhance tendon fixation because it contributes to the natural healing process and prevents the chronic inflammation that is present in other biodegradable devices.

What Are Latest Mergers And Acquisitions In The Orthopedic Biomaterials Market?

In September 2023, Enovis, a US-based medical technology company, acquired Lima Corporate for $ 847 million. Enovis expects the acquisition to bring it a number of attractive strategic advantages, including the chance to grow its successful recon portfolio and increase its global presence. Enovis would be able to achieve improved financial results with this acquisition's strong cross-selling revenue growth prospects and significant cost reductions. Lima Corporate is an Italy-based company that manufactures orthopedic biomaterials.

Regional Outlook

North America was the largest region in the orthopedic biomaterials market in 2025. Western Europe was the second largest region in the orthopedic biomaterials market report. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Orthopedic Biomaterials Market?

The orthopedic biomaterials market consists of sales of glass-ceramic and bioactive glasses and calcium phosphate cements. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.